GoldBamboo.com - Knowledge is strong medicine
  

Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy - Article


  Not Signed In - Sign In / Register






Bone Markers


Clinical Trial: Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy

This study is currently recruiting patients.
Verified by GTx August 2005

Sponsored by: GTx
Information provided by: GTx
ClinicalTrials.gov Identifier: NCT00129142

Purpose

Androgen Deprivation Therapy Treatment for prostate cancer decreases the natural hormone called testosterone. This type of therapy is very effective for the treatment of prostate cancer. However, one of the side effects is bone loss or thinning of the bones that can lead to osteoporosis and an increased risk of bone fractures (breaking of the bones). The purpose of the study is to determine whether or not the addition of toremifene citrate (the study drug) to therapy can prevent or decrease the number of bone fractures and to evaluate its impact on side effects associated with testosterone reduction therapy.
Condition Intervention Phase
Prostate Cancer
Osteoporosis
Bone Loss
Fractures
 Drug: Toremifene Citrate
Phase III

MedlinePlus related topics:  Fractures;   Osteoporosis;   Prostate Cancer

Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study

Official Title: A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

Further Study Details: 
Primary Outcomes: Percentage of subjects at 24 months with at least one new vertebral fracture determined by blinded central review of radiographs of the thoracic and lumbar spine
Secondary Outcomes: Percentage of subjects with at least one new or worsening vertebral fracture at 24 months; Percentage of subjects with a clinical fragility fracture at 12 and 24 months; Percent change from baseline in lumbar BMD as measured by DEXA scan at 24 months
Expected Total Enrollment:  1200

Study start: October 2003
Last follow-up: September 2007;  Data entry closure: January 2008

Eligibility

Ages Eligible for Study:  50 Years and above,  Genders Eligible for Study:  Male
Criteria

Inclusion Criteria:

  • To be eligible for participation in this study, subjects must meet all of the following criteria (minor deviations may be discussed with the medical monitor for possible inclusions):

• Give voluntary, signed informed consent in accordance with institutional policies • Be male, aged ≥ 50 years • Have histologically documented prostate cancer. Subjects with metastatic prostate cancer may still be considered for the study as long as they are not disqualified by other inclusion/exclusion criteria and there is a reasonable expectation that their medical condition will not interfere with the objectives of the study and that adequate follow-up and compliance with the study protocol can be achieved for the full 24-month duration of the study.

• Have been on a) ADT treatment (either LHRHa or orchiectomy) for at least 6 months. Or b) Intermittent LHRHa for at least the preceding 12 months is acceptable, but subjects must be maintained on uninterrupted treatment for the duration of this study once they are randomized into the study.

• a) Be aged ≥ 70 years or b) have BMD of lumbar spine or femoral neck at or below the specified thresholds for study entry

BMD Threshold Hologic BMD (g/cm2) Lunar BMD (g/cm2) L1-L4 0.926 1.050 Femoral Neck 0.717 0.840

Serum PSA ≤ 4 ng/mL • Have a Zubrod performance status ≤ 1 (See Appendix B) • Subject weight < 300 lbs (weight limitation of DEXA equipment) • Agree to complete a daily diary of medication intake and to provide tablet containers for accurate counts • Agree to use an effective method of contraception, if the partner is of childbearing age, while on study • Have adequate bone marrow, liver and renal function:  White Blood Cell (WBC) Count ≥ 3,000/mm3  Platelet Count ≥ 100,000/mm3  Bilirubin ≤ 1.5 mg/dL  AST and ALT < 2x upper limit of normal  Serum Creatinine ≤ 2.0 mg%

Exclusion Criteria:

  • Subjects with any of the following will not be eligible for enrollment:

• Taking bisphosphonates, SERMs, PTH, Forteo® (teriparatide), calcitonin, or oral glucocorticoids within 45 days of randomization • Have any disease or condition that would preclude an accurate evaluation of radiographs of the thoracic and lumbar spine (at least eight evaluable vertebrae in the range T4 to L4) (for example, severe scoliosis, or sequelae of orthopedic procedures or other surgery) • Have > 4 vertebral fragility fractures • Have any history of other carcinomas within the last 5 years (except nonmelanoma cutaneous malignancies and superficial bladder cancer with no evidence of recurrence which will not be excluded).

NOTE: Patients with cancers other than nonmelanoma cutaneous malignancies and superficial bladder cancer with no evidence of tumor recurrence for at least 5 years after definitive treatment will not be excluded from this study.

• Have Paget’s disease of bone • Have active systemic viral, bacterial or fungal infections requiring treatment • Have, in the judgment of the investigator, a clinically significant concurrent illness or psychological, familial, sociological, geographical or other concomitant condition that would not permit adequate follow-up and compliance with the study protocol for the full 24-month duration of the study • Received treatment with other investigational agents within 30 days prior to randomization • Taking finasteride (e.g., Proscar®), dutasteride (e.g., Avodart®), Danocrine® (danazol) or testosterone-like supplements, such as dehydroepiandrosterone (DHEA) (subject is eligible if he stops these agents for a total washout of 45 days prior to randomization and agrees not to use these agents for the duration of the study) • Taking herbal medicine or dietary supplements for prostate health, such as PC SPES and Saw Palmetto (also known as Seronea Pepens) (subject is eligible if he stops these agents for a total washout of 45 days prior to randomization and agrees not to use these agents for the duration of the study). Lycopene and selenium are not prohibited and no washout is required.

• Have a history of thromboembolic disease including deep vein thrombosis or pulmonary embolus • Have a history of chronic hepatitis or cirrhosis • Have received prior treatment with toremifene

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00129142

Joye O''''Rourke, BSN      901-523-9700  Ext. 117    jorourke@gtxinc.com
Leslie D Gooch, BS/CCRP      901-523-9700  Ext. 193    lgoochharris@gtxinc.com

Alabama
      Urology Centers of Alabama, Homewood,  Alabama,  35209,  United States; Recruiting
Cynthia Nasiogik  205-445-0125    cnasiogik@uca.medclinic.net 
Walter Pittman, MD,  Principal Investigator

      Coastal Clinical Research, Mobile,  Alabama,  36608,  United States; Recruiting
Julie Clark  251-414-1984    juliec@coastalclinicalresearch.com 
Charles White, MD,  Principal Investigator

Arkansas
      Arkansas Urology, Little Rock,  Arkansas,  72211,  United States; Recruiting
Anne Tursky  501-219-8900    anne@arkansasurology.com 
J. Walt Stallings, MD,  Principal Investigator

California
      Center of Urologic Research, La Mesa,  California,  91942,  United States; Recruiting
Tami Goebel  619-460-0595    tami@cursd.com 
Mohamed Bidair, MD,  Principal Investigator

      Pacific Clinical Research, Santa Monica,  California,  90404,  United States; Recruiting
Bertha Navarrete  310-829-1317    bnavarrete@pcrsm.com 
Stanley Brosman, MD,  Principal Investigator

      San Bernadino Urological Associates, San Bernadino,  California,  92404,  United States; Recruiting
Teresa Pedraza  909-882-3813    teresa@sburology.com 
Franklin Chu,  Principal Investigator

      Veterans Medical Research Foundation, San Diego,  California,  92161,  United States; Recruiting
Jane Jenkins  619-543-5579    j2jenkins@ucsd.edu 
Tracy Downs, MD,  Principal Investigator

      West Coast Clinical Research, Tarzana,  California,  91356,  United States; Recruiting
Teri Mata  818-901-8546  Ext. 118    tmata@wccresearch.com 
Eugene Dula, MD,  Principal Investigator

      Urological Physicians of San Diego, San Diego,  California,  92103,  United States; Recruiting
Karen Goodrum  619-299-0670    kgoodrum@aol.com 
Danny Keiller, MD,  Principal Investigator

      Urological Sciences Research Foudation, Culver City,  California,  90232,  United States; Recruiting
Malu Macairan  310-838-6347    mmacairan 
Leonard Marks, MD,  Principal Investigator

      Palo Alto VA, Palo Alto,  California,  94305,  United States; Recruiting
Karen Bratcher  650-493-5000  Ext. 64572    karen.bratcher@med.va.gov 
Stewart McCallum, MD,  Principal Investigator

      Urological Associates of Central CA, Fresno,  California,  93720,  United States; Recruiting
Rebekah Rau  559-321-2878    rrau@urologyassociates.net 
William Schiff, MD,  Principal Investigator

      Advanced Urology Medical Center Clinical Trials, Anaheim,  California,  92801,  United States; Recruiting
Vera Martinez  714-776-2030    advancedutotrial@aol.com 
Alfred Sidhom, MD,  Principal Investigator

      South Orange County Medical Research Center, Laguna Woods,  California,  92653,  United States; Recruiting
Kristy Putman  949-215-9515  Ext. 236    kputman@urologymedical.com 
Jay Young, MD,  Principal Investigator

      Western Clinical Research, Inc., Torrance,  California,  90505,  United States; Recruiting
Carolyn Ferguson  310-791-5634  Ext. 187    fergie@latrials.com 
Norman Zinner, MD,  Principal Investigator

Colorado
      Urology Associates, Denver,  Colorado,  80210,  United States; Recruiting
Tanya Frazier  303-733-8873  Ext. 1267    tfrazier@uradenver.com 
Barrett Cowan, MD,  Principal Investigator

      Western Urological Research, Wheat Ridge,  Colorado,  80033,  United States; Recruiting
Kevin Hare  303-421-5783    research@westernurologic.com 
Lawrence Karsh, MD,  Principal Investigator

Connecticut
      Connecticut Clinical Research, Waterbury,  Connecticut,  06708,  United States; Recruiting
Nancy Scacco  203-754-3588  Ext. 358    ccrcuro@aol.com 
Robert Feldman, MD,  Principal Investigator

      Urologic Center, New Haven,  Connecticut,  06511,  United States; Recruiting
Joanne Wilhelmy  203-789-2222    office@urologycenter.com 
Stanton Honig, MD,  Principal Investigator

      Urological Associates of Bridgeport, Trumball,  Connecticut,  06611,  United States; Recruiting
Katharine Nunnink  203-375-3456    cknunn@bpthosp.org 
Arthur Pinto, MD,  Principal Investigator

District of Columbia
      Walter Reed Army Medical Center, Washington,  District of Columbia,  20307,  United States; Recruiting
Stephanie Shaar  202-782-4207    stephanie.shaar@na.amedd.army.mil 
David McLeod, MD,  Principal Investigator

Florida
      UroSearch, Tavares,  Florida,  32778,  United States; Recruiting
 352-732-6040    urosearch@atlantic.net 
Charles Cartwright, MD,  Principal Investigator

      Central Florida Urology Group/ UroSearch, Ocala,  Florida,  34474,  United States; Recruiting
 352-732-6040    urosearch@atlantic.net 
David Cunningham, MD,  Principal Investigator

      Atlantic Urological Associates, Daytona Beach,  Florida,  32114,  United States; Recruiting
Jonelle Horsley  386-239-8585    jhorsley@atlanticurology.com 
Martin Dineen, MD,  Principal Investigator

      Tampa Bay Urology, Tampa,  Florida,  33607,  United States; Recruiting
Linda Haynie  813-872-7881    LA@ISRnet.com 
Todd Fusia, MD,  Principal Investigator

      South Florida Medical Research, Aventura,  Florida,  33180,  United States; Recruiting
Sayonara Nunez  305-931-8080  Ext. 21    snunez@southfloridamedicalresearch.com 
Marc Gittleman, MD,  Principal Investigator

      Pinellas Urology, St. Petersburg,  Florida,  33710,  United States; Recruiting
Bronson Oudshoff  727-381-8667    research@pinellasurology.com 
Sean Heron, MD,  Principal Investigator

      Lakeland Regional Medical Center, Lakeland,  Florida,  33805,  United States; Recruiting
Robin Stewart  863-904-1885  Ext. 1104    robin.stewart@lrmc.com 
Byron Hodge, MD,  Principal Investigator

      Winter Park Urology Associates, Orlando,  Florida,  32803,  United States; Recruiting
Sharon Livingstone  407-897-3499    sharonlivingstone@wpuafl.com 
David Jablonski, MD,  Principal Investigator

      Panama City Urology, Panama City Beach,  Florida,  32405,  United States; Recruiting
Beverly Bond  850-785-8557    pcuresearch@hotmail.com 
Mike Jenkins, MD,  Principal Investigator

      Florida Foundation for Healthcare Research, Ocala,  Florida,  34474,  United States; Recruiting
Joanne Grover  352-237-8100  Ext. 275    jgrover@floridahr.com 
Ira Klimberg, MD,  Principal Investigator

      Cleveland Clinic-Florida, Weston,  Florida,  33331,  United States; Recruiting
Eida Gomez  954-359-5199    gomeze2@ccf.org 
Nicholas Muruve, MD,  Principal Investigator

      Southeastern Research Group, Tallahassee,  Florida,  32308,  United States; Recruiting
Mary Ann Taylor  850-201-0411  Ext. 470    rschcrc@seuc.com 
Raleigh Rollins, MD,  Principal Investigator

      Advance Research Institute, New Port Richey,  Florida,  34652,  United States; Recruiting
Nora Merrill  727-842-9561  Ext. 263    merillnari@yahoo.com 
Jerrold Sharkey, MD,  Principal Investigator

      Urosearch, Inverness,  Florida,  34452,  United States; Recruiting
 352-732-6040    urosearch@atlantic.net 
Thomas Stringer, MD,  Principal Investigator

      Urology Consultants Inc., Clearwater,  Florida,  33761,  United States; Recruiting
Phyllis Wattleworth  727-797-3281    phyllis@urologyconsultantsfla.com 
James M Zachary, MD,  Principal Investigator

Georgia
      Midtown Urology, Atlanta,  Georgia,  30308,  United States; Recruiting
Nathan Smith  404-881-0965  Ext. 117    nsmith@midtown-urology.com 
James K Bennett, MD,  Principal Investigator

      Augusta VAMC, Augusta,  Georgia,  30912,  United States; Recruiting
Carol Smith  706-721-0193    csmith@mcg.edu 
James A. Brown, MD,  Principal Investigator

      Harbin Clinic Department of Urology Research, Rome,  Georgia,  30165,  United States; Recruiting
Sheila Day  706-232-1437    sday@harbinclinic.com 
James Crane,  Principal Investigator

      Southeastern Medical Research Institute, Columbus,  Georgia,  31904,  United States; Recruiting
Stepahnie Thomas  706-324-7700    thomass@harperurology.com 
William Harper, MD,  Principal Investigator

      Georgia Urology, Atlanta,  Georgia,  30342,  United States; Recruiting
Cheryl Simpson  404-943-1957    cheryl.simpson@gaurology.com 
Emerson Harrison, MD,  Principal Investigator

      North Fulton Urology, Roswell,  Georgia,  30076,  United States; Recruiting
Cindy Nelson  770-752-8632    cnelson@nfurology.com 
Lewis Kriteman, MD,  Principal Investigator

      St. Joseph''''s, Candler Health System, Savannah,  Georgia,  31405,  United States; Recruiting
Wanda North  912-819-6194    northw@sjchs.org 
Richard Mazo, MD,  Principal Investigator

      Urology Enterprises, Marietta,  Georgia,  30060,  United States; Recruiting
Becky Hippensteel  770-428-6478    beckyhippensteel@yahoo.com 
Ronald Roper, MD,  Principal Investigator

      St. Joseph Research Institute, Atlanta,  Georgia,  30342,  United States; Recruiting
Rhonda Kendrick  404-255-3822    rkendrick@sjha.org 
Holt Sanders, MD,  Principal Investigator

Idaho
      North Idaho Urology, Coeur D Alene,  Idaho,  83814,  United States; Recruiting
Pat Vancaster  208-667-0621    pvancaster@niurology.com 
Randil Clark, MD,  Principal Investigator

Illinois
      Special Care Research, Peoria,  Illinois,  61614,  United States; Recruiting
Dawn Wimmer  309-683-1125    puareasearch@yahoo.com 
Giovanni Columbo, MD,  Principal Investigator

      Prairie Medical Associates, Chicago,  Illinois,  60616,  United States; Recruiting
Urakay Juett  312-842-4400    urakay@urologychicago.com 
Terry Mason, MD,  Principal Investigator

      Medical and Surgical Specialists, Galesburg,  Illinois,  61401,  United States; Recruiting
Gina Riner  309-343-2262    griner@grics.net 
Thomas Patterson, MD,  Principal Investigator

Indiana
      Metropolitan Urology, Jeffersonville,  Indiana,  47130,  United States; Recruiting
Debbie Johnson  812-288-2611    d.johnson@metropolitanurology.com 
James Bailen, MD,  Principal Investigator

      Urology of Indiana, LLC, Greenwood,  Indiana,  46143,  United States; Recruiting
Angie Summers  317-893-1511    asummers@urologyin.com 
Terry Jones, MD,  Principal Investigator

      MMPC Urology, Greenwood,  Indiana,  49546,  United States; Recruiting
Sue Engerman  616-974-4604    sengerman@mmpc.com 
Richard Kahnoski, MD,  Principal Investigator

Kansas
      Heartland Research Associates, LLC, Wichita,  Kansas,  67207,  United States; Recruiting
Sheri L. Duncan  316-689-6635    sduncan@heartlandresearch.com 
Terry Poling, MD,  Principal Investigator

Louisiana
      Regional Urology LLC, Shreveport,  Louisiana,  71106,  United States; Recruiting
Leah Stehr  318-683-0411  Ext. 154    lstehr@regionalurology.com 
David Price, MD,  Principal Investigator

      LSUHSC/Stanley Scott Cancer Center, New Orleans,  Louisiana,  70112,  United States; Recruiting
Alisa Trout  504-568-8286    atrout@lsuhsc.edu 
Oliver Sartor, MD,  Principal Investigator

Maryland
      Urology Center, PA, Hagerstown,  Maryland,  21742,  United States; Recruiting
Dan Lemont  301-733-0022    dwarek@aol.com 
Kevin Hackett, MD,  Principal Investigator

      Maryland Prostate Center: University of Maryland Medical Center, Baltimore,  Maryland,  21201,  United States; Recruiting
Ganine Markowitz  410-328-0801    gmarkowitz@smail.umaruland.edu 
Michael Naslund, MD,  Principal Investigator

      Anne Arundel Urology P.A., Annapolis,  Maryland,  21401,  United States; Recruiting
Elizabeth D''''Antonio  410-266-8049  Ext. 143    landantonio@aaurology.com 
Eric Schwartz, MD,  Principal Investigator

      Mid Atlantic Clinical Research, Rockville,  Maryland,  28050,  United States; Recruiting
Jackie Rosario  301-315-6081    rosariojackie1@msn.com 
Jonathan White, MD,  Principal Investigator

Massachusetts
      The Fallon Clinic, Worcester,  Massachusetts,  01605,  United States; Recruiting
Diane Davis  508-595-2195    diane.davis@fallon-clinic.com 
Mitchell Bamberger, MD,  Principal Investigator

      Wayne Glazier, Worcester,  Massachusetts,  01605,  United States; Recruiting
Linda Dodge  508-753-1298    dodgeaprn006@yahoo.com 
Wayne Glazier, MD,  Principal Investigator

Michigan
      Beaumont Medical, Royal Oak,  Michigan,  48073,  United States; Recruiting
Melissa Degraw  248-551-0804    madegraw@beaumont.edu 
Ananias Diokno, MD,  Principal Investigator

      University of Michigan Comprehensive Cancer Center, Ann Arbor,  Michigan,  48109,  United States; Recruiting
Cynthia Rekowski  734-647-9437    crekowsk@umich.edu 
Ken Pienta, MD,  Principal Investigator

Minnesota
      Park Nicollet Urology, St. Louis Park,  Minnesota,  55416,  United States; Recruiting
Linda Kuno  952-993-1926    kunol@parknicollet.com 
William Borkon, MD,  Principal Investigator

      Mayo Clinic Urology Department, Rochester,  Minnesota,  55905,  United States; Recruiting
Jane Smith  507-266-4446    smith.jane2@mayo.edu 
Ajay Nehra, MD,  Principal Investigator

Missouri
      Urologic Research Center, St. Louis,  Missouri,  63141,  United States; Not yet recruiting
Karen Civitelli  314-996-8282    civitellik@wash.edu 
Arnold Bullock, MD,  Principal Investigator

      PPS Clinical Research, St. Louis,  Missouri,  63141,  United States; Recruiting
Marilyn Cauley  314-692-8013    mcauley@ppscr.com 
Jay Patel, MD,  Principal Investigator

      Kansas City Urology, PC, Kansas,  Missouri,  64131,  United States; Recruiting
Shannon Cone  816-333-5433    scone@kcurology.com 
Brandon Pomeroy, MD,  Principal Investigator

Nevada
      Sheldon Freeman, Las Vegas,  Nevada,  89109,  United States; Recruiting
Syd Warner  702-732-0282    sydwarner@yahoo.com 
Sheldon Freedman, MD,  Principal Investigator

      Urologic Surgeons, Ltd., Reno,  Nevada,  89502,  United States; Not yet recruiting
Lorry Duncan  775-284-1614    lduncan@urosurg.net 
John Scott, MD,  Principal Investigator

New Jersey
      Urology Healthcare Associates, Willingboro,  New Jersey,  08046,  United States; Recruiting
Marilyn Behler, RN  609-877-8400    pmb@fast.net 
Scott Asroff, MD,  Principal Investigator

      Coastal Urology Associates, Brick,  New Jersey,  08724,  United States; Recruiting
Susan Messler  732-840-4300    snaponpete@zaol.com 
Daniel Burzon, MD,  Principal Investigator

      Lawrenceville Urology Associates, Lawrenceville,  New Jersey,  08648,  United States; Recruiting
Beverly Davis  609-895-0735  Ext. 110    bev.davis05@comcast.net 
Gary S Karlin, MD,  Principal Investigator

      Hamilton Urology PA, Hamilton,  New Jersey,  08690,  United States; Recruiting
Sukanya Skanbarajah  609-588-5300    sskanbarajah@odesseyresearch.org 
Earl Linder, MD,  Principal Investigator

      Assoc. Urologic Specialists, Marlton,  New Jersey,  08053,  United States; Recruiting
Beverly Pfeifer  856-985-4286    bpfeiferausnj.com 
Neil Phillips, MD,  Principal Investigator

New Mexico
      Urology Group of New Mexico, Albuquerque,  New Mexico,  87109,  United States; Recruiting
Carla Jennings  505-872-4090  Ext. 118    research@ugnm.com 
Frederick Snoy, MD,  Principal Investigator

New York
      Center for Urologic Research WNY, LLC, Williamsville,  New York,  14221,  United States; Recruiting
Debbie D''''Orazio, RN, CCRC  716-631-9654    pjaresearchofwny@mainurology.com 
Phillip Aliotta, MD,  Principal Investigator

      Metropolitan Urologic Services, PC, Elmont,  New York,  11003,  United States; Recruiting
Carlos Saavedra  516-328-8775    metrouro@aol.com 
Carlton Barnswell, MD,  Principal Investigator

      Urological Surgeons of Long Island, Garden City,  New York,  11530,  United States; Recruiting
Marissa Schulman  516-742-3200    golmy@aol.com 
Robert Edelman, MD,  Principal Investigator

      Urology Inst. Of New York, Albany,  New York,  12208,  United States; Recruiting
Brenda Romeo  518-262-8579    ccpurologyresearch@communitycare.com 
Hugh Fisher, MD,  Principal Investigator

      Mount Sinai School of Medicine, New York,  New York,  10029,  United States; Recruiting
Cynthia Knauer  212-241-8121    cynthia.knauer@mountsinai.org 
Simon Hall, MD,  Principal Investigator

      Staten Island Urological Research , PC, Staten Island,  New York,  10304,  United States; Recruiting
Nicole Zampardi  718-720-6040    urology2@si.rr.com 
Ron Israeli, MD,  Principal Investigator

      University Urology Associates, New York,  New York,  10016,  United States; Recruiting
Betsy Ortiz  212-686-9015    betsyortiz@yahoo.com 
Jed Kaminetsky, MD,  Principal Investigator

      Associated Urologists of CNY, Syracuse,  New York,  13210,  United States; Recruiting
Michelle Bass  315-478-4185    mbass@twcny.rr.com 
Joel Bass, MD,  Principal Investigator

      William Oberheim, Albany,  New York,  12208,  United States; Recruiting
Cheryl Aikey  518-438-4471    ewilliamsoberh@nycap.rr.com 
William Oberheim, MD,  Principal Investigator

      CNY Urology, Oneida,  New York,  13421,  United States; Recruiting
Kimberly Barres  315-363-8862    cnyurology@yahoo.com 
Basha Omarbasha, MD,  Principal Investigator

North Carolina
      University of North Carolina, Chapel Hill,  North Carolina,  27559,  United States; Recruiting
Cooki Senter  919-966-9253    cooki_senter@med.va.gov 
Cully Carson, MD,  Principal Investigator

      Piedmont Medical Research Associates, Winston Salem,  North Carolina,  27103,  United States; Recruiting
Emily Cook  336-768-8062    ecook@piedmontmedical.com 
David Cook, MD,  Principal Investigator

      Asheboro Urology, Asheboro,  North Carolina,  27203,  United States; Recruiting
Debbie Davis  336-625-3997    christie.barnes@earthlink.net 
Prithivi Hanspal, MD,  Principal Investigator

      Wake Urology, Raleigh,  North Carolina,  27607,  United States; Recruiting
Mary Hester  919-782-1255    wakeurol@aol.com 
Richard Kane, MD,  Principal Investigator

      The Urology Center, Greensboro,  North Carolina,  27403,  United States; Recruiting
Jillian Angel  336-274-1114  Ext. 5383    jangel@tucpa.com 
Sigmund Tannenbaum, MD,  Principal Investigator

North Dakota
      Odyssey Research, Bismarck,  North Dakota,  58501,  United States; Recruiting
Laurie Holverson  701-250-8420    lholverson@odysseyresearch.org 
Leslie Rainwater, MD,  Principal Investigator

Ohio
      Southwest Urology, Parma,  Ohio,  44129,  United States; Recruiting
Kim Cristantiello  440-845-0900    southwest@southwesturology.com 
Michael Berte, MD,  Principal Investigator

      Colombus Urology Research, Columbus,  Ohio,  43214,  United States; Recruiting
Janice Rosenthal  614-457-6028    pam@columbusurology.com 
David H. Brown, MD,  Principal Investigator

      Cleveland Clinic Lerner College of Medicine, Cleveland,  Ohio,  44195,  United States; Recruiting
Benjamin Haraway  216-445-4623    harawab@ccf.org 
Robert Dreicer, MD,  Principal Investigator

      The Urology Group, Cincinnati,  Ohio,  45212,  United States; Recruiting
Vicki Rice  513-366-3412    vrice@theurologygroup.cc 
William Monnig, MD,  Principal Investigator

      Summa Health Care, Akron,  Ohio,  44304,  United States; Recruiting
Nancy Rinella  330-375-4221    rinellan@summa-health.org 
Michael ` Seider, MD,  Principal Investigator

      Urology of Northern Ohio, Elyria,  Ohio,  44035,  United States; Recruiting
Diane Spirnak  440-930-6060    papirnak@metrohealth.org 
J.P. Spirnak, MD,  Principal Investigator

Oklahoma
      Oklahoma University Medical Center, Oklahoma City,  Oklahoma,  73104,  United States; Recruiting
Karen Mataranglo  405-271-6900    Karen-Mataranglo@ouhsc.edu 
Daniel Culkin, MD,  Principal Investigator

      Urologic Specialists of Oklahoma, Inc., Tulsa,  Oklahoma,  12208,  United States; Recruiting
June Jordan  918-392-2290    jjordan@urologicspecialists.com 
John Forrest, MD,  Principal Investigator

Oregon
      The Corvallis Clinic, Corvallis,  Oregon,  97330,  United States; Recruiting
Pat Eshelman  541-753-1618  Ext. 1029    pat.eshleman@corvallis-clinic.com 
Peter Kenyon, MD,  Principal Investigator

      Oregon Urology Specialists, Springfield,  Oregon,  97477,  United States; Recruiting
Janice Beebe  541-284-5508 
Bryan Mehlhaff, MD,  Principal Investigator

Pennsylvania
      Urologic Surgery, Bala Cynwyd,  Pennsylvania,  19004,  United States; Recruiting
Cheryl Zinar  610-667-3020  Ext. 16    urologicresearch@attglobal.net 
Lawrence Belkoff, MD,  Principal Investigator

      The Urology Institute, Monroeville,  Pennsylvania,  15146,  United States; Recruiting
Julie Bachalis  412-373-2333    jmbachalis@hotmail.com 
Frank Costa, MD,  Principal Investigator

      State College Urologic Association, State College,  Pennsylvania,  16801,  United States; Recruiting
Amy Folk  814-238-8418    folka@scurologic 
Charles Dalton, MD,  Principal Investigator

      University of Pittsburg, Pittsburg,  Pennsylvania,  15232,  United States; Recruiting
Colette Spinarelli  412-605-3031    colette.spinarelli@med.va.gov 
Jeff Gingrich, MD,  Principal Investigator

      Ginsberg and Harkaway Urology, Philadelphia,  Pennsylvania,  19141,  United States; Recruiting
Rose Mary Sandy  215-456-1177    sandyr@einstein.edu 
Phillip Ginsberg, MD,  Principal Investigator

      University of Pennsylvania, Philadelphia,  Pennsylvania,  19104,  United States; Recruiting
Lilliam Ribeiro  215-615-3780    lilliam.ribeiro@uphs.upenn.edu 
Bruce Malkowicz, MD,  Principal Investigator

      Urologic Associates of Allentown, Allentown,  Pennsylvania,  18103,  United States; Recruiting
Kathleen Post  610-437-9988    kathleen.post@lvh.com 
Brian Murphy, MD,  Principal Investigator

      University of Pittsburgh, Pittsburgh,  Pennsylvania,  15232,  United States; Recruiting
Lauri-Ann Hahn  412-605-3031    hahnla@upmc.edu 
Joel Nelson, MD,  Principal Investigator

      Urological Associates of Lancaster, Ltd., Lancaster,  Pennsylvania,  17604,  United States; Recruiting
Dorie Rodriguez  717-431-2285    ualresearch@yahoo.com 
Paul Sieber, MD,  Principal Investigator

Rhode Island
      University Urological Research Institute, Providence,  Rhode Island,  02904,  United States; Recruiting
Betsy Parrott  401-272-7799    bparrott@urologyri.com 
Barry Stein, MD,  Principal Investigator

South Carolina
      Carolina Urologic Research Center, Myrtle Beach,  South Carolina,  29572,  United States; Recruiting
Stacey Harrelson  843-839-1679    sharrel@grandstrandurology.com 
Brian Roberts, MD,  Principal Investigator

      Radiant Research, Greer,  South Carolina,  29651,  United States; Recruiting
Heather Warner  864-877-9239    heatherwarner@radiantresearch.com 
John Walton, MD,  Principal Investigator

Tennessee
      Urology Associates, Nashville,  Tennessee,  37209,  United States; Recruiting
Rick Trotter  615-250-9268    crtrotter@cimplify.net 
David Bilhartz, MD,  Principal Investigator

      Vanderbilt Medical Center, Nashville,  Tennessee,  37232,  United States; Recruiting
Pam Steele  615-343-0445    pam.steele@vanderbilt.edu 
Michael Cookson, MD,  Principal Investigator

      Volunteer Research Group, Knoxville,  Tennessee,  37920,  United States; Recruiting
Carla Spurgeon  865-544-9356    cspurgeo@mc.utmck.edu 
Paul Hatcher, MD,  Principal Investigator

      Center for Urological Treatment, Nashville,  Tennessee,  37203,  United States; Recruiting
Rhayghen Ashby  615-342-5700    rhayghenashby@hotmail.com 
Dean Knoll, MD,  Principal Investigator

      Southeast Urology Network, Memphis,  Tennessee,  38119,  United States; Recruiting
T.J. Brace  901-527-7100    tjbrace@mdnet.net 
Mark Saslawsky, MD,  Principal Investigator

      Ace Research Specialists, Nashville,  Tennessee,  37203,  United States; Recruiting
Debbie Shepherd  615-844-1223    aceresearch@earthlink.net 
Michael Spalding, MD,  Principal Investigator

Texas
      Professional Quality Research, Austin,  Texas,  78756,  United States; Recruiting
Amy Sasser  512-374-1677  Ext. 16    asasser@pqrinc.com 
Richard Chopp, MD,  Principal Investigator

      Breco Research, Houston,  Texas,  77024,  United States; Recruiting
Patricia Mendoza  713-973-6993    pmendoza@brecoresearch.com 
Mark Kalish, MD,  Principal Investigator

      Scott and White Clinical Hospital, Temple,  Texas,  76508,  United States; Recruiting
Karen Wynn  254-724-5512    sdstern@swmail.sw.org 
Belur Patel, MD,  Principal Investigator

      Urology San Antonio Research, PA, San Antonio,  Texas,  78229,  United States; Recruiting
Diana Strange  210-617-4116    dianas@urologysanantonio.com 
Daniel Saltzstein, MD,  Principal Investigator

      Urology Consultants, PA, San Antonio,  Texas,  78229,  United States; Recruiting
Kimberly Paz  210-616-0410    research@urologyconsults.com 
Sammy Vick, MD,  Principal Investigator

Utah
      Salt Lake City Research, Salt Lake City,  Utah,  84124,  United States; Recruiting
Heather Drips  801-288-9778    heatherlyndrips@yahoo.com 
Lane Childs, MD,  Principal Investigator

Virginia
      Devine Tidewater Urology, Norfolk,  Virginia,  23502,  United States; Recruiting
Bethany Gambill  757-457-5164    bgambill@urologyofva.com 
Robert Given, MD,  Principal Investigator

      McGuire VA Medical Center, Richmond,  Virginia,  23249,  United States; Recruiting
Pamela Summers  804-675-5409    pamela.summers@med.va.gov 
Mayer Grob, MD,  Principal Investigator

      Med Atlantic, Inc (Virginia Urology), Richmond,  Virginia,  23235,  United States; Recruiting
Nada Wood  804-560-4483    nada @uro.com 
James McMurtry, MD,  Principal Investigator

      Adult and Pediatric Urologist of Northern VA, Alexandria,  Virginia,  22304,  United States; Recruiting
Barbara Chalom  703-370-2132    chalomb@comcast.net 
George Tawil, MD,  Principal Investigator

Washington
      Deaconess Medical Center, Spokane,  Washington,  99204,  United States; Recruiting
Monica Ponder  509-473-3480    ponderm@empirehealth.org 
Thomas Fairchild, MD,  Principal Investigator

      Seattle VAMC, Seattle,  Washington,  98108,  United States; Recruiting
Judy Stenstrom  206-277-4368    judy.stenstrom@med.va.gov 
Daniel Lin, MD,  Principal Investigator

      Madigan Army Medical Center, Tacoma,  Washington,  98431,  United States; Recruiting
Tammy Bousquet-Cordes  253-968-0798 
Keith O''''Reilly, MD,  Principal Investigator

Wisconsin
      Froedtert Memorial Lutheran Hospital Department of Urology, Milwaukee,  Wisconsin,  53226,  United States; Recruiting
Holly Kelly  414-456-7059    hkelly@mail.mcw.edu 
Robert Donnell,  Principal Investigator

      University of Wisconsin Medical School: Clinical Trials, Madison,  Wisconsin,  53715,  United States; Recruiting
Barbara Bowman  608-287-2861    bab@clinicaltrials.wisc.edu 
David Paolone, MD,  Principal Investigator

      St. Michael''''s Hospital, Milwaukee,  Wisconsin,  53209,  United States; Recruiting
Ann Dwyer  414-527-3056    adwyer@midwestresearch.net 
Mitchell Wiatrak, MD,  Principal Investigator

Wyoming
      Wyoming Research Foundation, Cheyenne,  Wyoming,  82001,  United States; Recruiting
Deb Patterson  307-637-8183    wyomingresearch@yahoo.com 
John Bryant, MD,  Principal Investigator

Study chairs or principal investigators

Robert S. Boger, M.D.,  Study Director,  GTx   

More Information

Study ID Numbers:  G300203
Last Updated:  August 10, 2005
Record first received:  August 9, 2005
ClinicalTrials.gov Identifier:  NCT00129142
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-23


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Bone Markers.

October 11, 2008



Page Updated: February 22, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.